Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
NASDAQ
16.302,76
-0,18%
Bitcoin
61.643,05
-1,11%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Titan Pharmaceuticals Inc (TTNP) Titan Pharmaceuticals Inc (TTNP) Notizie

TTNP

Titan Pharmaceuticals (TTNP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTNP
DataOraFonteTitoloSimboloCompagnia
25/01/202422:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
25/01/202422:29GlobeNewswire Inc.Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaNASDAQ:TTNPTitan Pharmaceuticals Inc
28/12/202322:15GlobeNewswire Inc.Titan Pharmaceuticals Announces Reverse Stock Split and RatioNASDAQ:TTNPTitan Pharmaceuticals Inc
28/11/202322:47Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
17/11/202322:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202322:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
24/10/202323:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TTNPTitan Pharmaceuticals Inc
23/10/202321:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
16/10/202322:37GlobeNewswire Inc.Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsNASDAQ:TTNPTitan Pharmaceuticals Inc
04/10/202323:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TTNPTitan Pharmaceuticals Inc
19/09/202322:41Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
18/09/202313:30GlobeNewswire Inc.Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockNASDAQ:TTNPTitan Pharmaceuticals Inc
14/08/202323:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTNPTitan Pharmaceuticals Inc
01/08/202301:45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
27/07/202313:30GlobeNewswire Inc.Titan Pharmaceuticals Announces Sale of Certain ProNeura AssetsNASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202322:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202322:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202315:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202315:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/05/202322:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/04/202322:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
31/03/202322:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/12/202213:00GlobeNewswire Inc.Titan Pharmaceuticals Provides Shareholder UpdateNASDAQ:TTNPTitan Pharmaceuticals Inc
12/12/202213:49GlobeNewswire Inc.UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.NASDAQ:TTNPTitan Pharmaceuticals Inc
30/08/202222:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TTNPTitan Pharmaceuticals Inc
16/08/202216:53PR Newswire (US)Titan Pharmaceuticals Announces Board Expansion and Management ChangesNASDAQ:TTNPTitan Pharmaceuticals Inc
25/07/202220:05Edgar (US Regulatory)Proxy Statement - Non-management (definitive) (defn14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
14/07/202218:48Edgar (US Regulatory)Proxy Statements Not Involving Contested Solicitations (preliminary) (pren14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202222:00Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202214:00GlobeNewswire Inc.Activist Investing Nominates Slate of Highly Qualified Director Candidates for Election to the Board of Directors of Titan Pharmaceuticals at Upcoming Special Meeting of StockholdersNASDAQ:TTNPTitan Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTNP

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
CPR
Davide Campari
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
FBK
Finecobank
BIT
TRN
Terna Trasmissione Elett...
BIT
IRE
Iren
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network